fusion conferences

Oncomatryx at the “Cancer Metabolism and the Tumour Microenvironment Conference”.

9-12, November. Paphos, Cyprus.

Myriam Fabre, PhD. (Oncomatryx R&D Director) will attend the conference as speaker:
TARGETING TUMOR MICROENVIRONMENT TO TREAT INVASIVE TUMORS: OMTX705, A POWERFUL FAP-SPECIFIC ANTIBODY-DRUG CONJUGATE.

More info

If you are also attending the conference and would like to meet us please fill this form to arrange an appointment.

Your Name (required)

Your Email (required)

Your Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>